News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
663,812 Results
Type
Article (53229)
Company Profile (203)
Press Release (610380)
Multimedia
Podcasts (81)
Webinars (9)
Section
Business (184196)
Career Advice (2731)
Deals (33832)
Drug Delivery (117)
Drug Development (79252)
Employer Resources (169)
FDA (16593)
Job Trends (15601)
News (323093)
Policy (32877)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2870)
Accelerated approval (6)
Adcomms (28)
Allergies (88)
Alliances (47389)
ALS (91)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (134)
Approvals (16565)
Artificial intelligence (267)
Autoimmune disease (24)
Automation (14)
Bankruptcy (347)
Best Places to Work (11928)
BIOSECURE Act (19)
Biosimilars (115)
Biotechnology (137)
Bladder cancer (66)
Brain cancer (30)
Breast cancer (273)
Cancer (2136)
Cardiovascular disease (186)
Career advice (2301)
Career pathing (32)
CAR-T (156)
Cell therapy (428)
Cervical cancer (20)
Clinical research (64516)
Collaboration (830)
Compensation (229)
Complete response letters (30)
COVID-19 (2833)
CRISPR (43)
C-suite (235)
Cystic fibrosis (106)
Data (2035)
Decentralized trials (2)
Denatured (24)
Depression (50)
Diabetes (271)
Diagnostics (6588)
Digital health (19)
Diversity (5)
Diversity, equity & inclusion (38)
Drug discovery (121)
Drug pricing (114)
Drug shortages (29)
Duchenne muscular dystrophy (96)
Earnings (69298)
Editorial (41)
Employer branding (22)
Employer resources (148)
Events (101784)
Executive appointments (693)
FDA (17781)
Featured Employer (40)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (723)
Gene editing (107)
Generative AI (28)
Gene therapy (313)
GLP-1 (799)
Government (4761)
Grass and pollen (5)
Guidances (50)
Healthcare (19582)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (129)
Indications (26)
Infectious disease (2986)
Inflammatory bowel disease (136)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (93)
Interviews (511)
IPO (15118)
IRA (44)
Job creations (4092)
Job search strategy (1924)
Kidney cancer (10)
Labor market (29)
Layoffs (523)
Leadership (21)
Legal (7530)
Liver cancer (78)
Lung cancer (313)
Lymphoma (138)
Machine learning (4)
Management (61)
Manufacturing (288)
MASH (65)
Medical device (13696)
Medtech (13701)
Mergers & acquisitions (19179)
Metabolic disorders (718)
Multiple sclerosis (78)
NASH (21)
Neurodegenerative disease (104)
Neuropsychiatric disorders (29)
Neuroscience (1975)
NextGen: Class of 2025 (6975)
Non-profit (4909)
Northern California (2397)
Now hiring (31)
Obesity (391)
Opinion (247)
Ovarian cancer (74)
Pain (89)
Pancreatic cancer (78)
Parkinson's disease (150)
Partnered (19)
Patents (208)
Patient recruitment (99)
Peanut (50)
People (55423)
Pharmaceutical (39)
Pharmacy benefit managers (20)
Phase I (20032)
Phase II (28155)
Phase III (21647)
Pipeline (1120)
Policy (139)
Postmarket research (2578)
Preclinical (7780)
Press Release (63)
Prostate cancer (98)
Psychedelics (35)
Radiopharmaceuticals (244)
Rare diseases (397)
Real estate (5792)
Recruiting (70)
Regulatory (22700)
Reports (35)
Research institute (2523)
Resumes & cover letters (414)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (75)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (56)
Southern California (2158)
Special edition (17)
Spinal muscular atrophy (157)
Sponsored (27)
Startups (3631)
State (1)
Stomach cancer (15)
Supply chain (67)
Tariffs (19)
The Weekly (55)
United States (20782)
Vaccines (768)
Venture capitalists (39)
Weight loss (277)
Women's health (32)
Worklife (19)
Date
Today (23)
Last 7 days (456)
Last 30 days (2393)
Last 365 days (32328)
2025 (8678)
2024 (34395)
2023 (39266)
2022 (50189)
2021 (54917)
2020 (54214)
2019 (48018)
2018 (36745)
2017 (32938)
2016 (32503)
2015 (37108)
2014 (28743)
2013 (23745)
2012 (25519)
2011 (26205)
2010 (23386)
Location
Africa (946)
Alabama (55)
Alaska (7)
Arizona (178)
Arkansas (14)
Asia (39069)
Australia (6684)
California (5585)
Canada (1747)
China (481)
Colorado (255)
Connecticut (259)
Delaware (119)
Europe (89847)
Florida (785)
Georgia (194)
Hawaii (1)
Idaho (60)
Illinois (512)
India (26)
Indiana (306)
Iowa (8)
Japan (146)
Kansas (96)
Kentucky (25)
Louisiana (11)
Maine (68)
Maryland (826)
Massachusetts (3918)
Michigan (217)
Minnesota (357)
Mississippi (2)
Missouri (86)
Montana (27)
Nebraska (25)
Nevada (51)
New Hampshire (68)
New Jersey (1526)
New Mexico (30)
New York (1548)
North Carolina (945)
North Dakota (8)
Northern California (2397)
Ohio (185)
Oklahoma (14)
Oregon (34)
Pennsylvania (1183)
Puerto Rico (10)
Rhode Island (26)
South America (1301)
South Carolina (19)
South Dakota (1)
Southern California (2158)
Tennessee (96)
Texas (772)
Utah (180)
Virginia (135)
Washington D.C. (60)
Washington State (515)
West Virginia (3)
Wisconsin (50)
663,812 Results for "helsinn healthcare sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Helsinn Group submits a new formulation of AKYNZEO® to the European Medicines Agency (EMA)
April 2, 2025
·
2 min read
Helsinn Group announces AKYNZEO® (fosnetupitant/palonosetron) injection is now available in a ready-to-use vial in the US
Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive care, oncology and dermato-oncology, is pleased to announce that AKYNZEO® (fosnetupitant/palonosetron) injection is now available in the US in a ready-to-use vial.
June 24, 2024
·
5 min read
Press Releases
Helsinn Group appoints Riccardo Carbucicchio to the Board of Directors
September 20, 2024
·
2 min read
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn Group announces the signing of a new financing agreement with BancaStato, effective from September 2023.
October 10, 2023
·
3 min read
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
Helsinn announces publication of data evaluating impact of AKYNZEO® (fosnetupitant/palonosetron) on treatment outcomes and healthcare costs
Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a strong focus in oncology and rare diseases, announces the publication of real-world evidence of AKYNZEO® (fosnetupitant with palonosetron) injection/for injection in the journal Advances in Therapy.
June 12, 2023
·
8 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
Business
Helsinn Healthcare SA signs exclusive license agreement with Juniper Biologics Pte. Ltd. for LEDAGA® (chlormethine) in Australia, Asia and the Middle East*
Helsinn Group and Juniper Biologics Pte Ltd announced the signing of an exclusive distribution license and supply agreement to register, distribute, promote, market and sell LEDAGA® in Australia, Asia and the Middle East* as a topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma in adults.
September 1, 2022
·
4 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
1 of 66,382
Next
